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We used a standard polymerase chain reaction (PCR)/ 
Southern blot assay (sensitivity> 10- 5) to detect hu-
m.an T-cell lymphotrophic virus type I (HTLV-I) 
proviral pX, pol, and env genes in the lesional skin of 
42 American patients with cutaneous T-cell lym-
phoma (CTCL). As in some prior reports using similar 
m.ethods, a variable proportion of PCR tests were 
positive (seven of 42 for pX, three of 42 for pol, and 
t-wo of 37 for env), resulting in an overall positive test 
rate of 12 of 121 (10%). To determine the significance 
of these positive test results, we performed several 
additional studies. D1S80 polymorphism analysis of 
CTCL cases and HTL V -I PCR analysis of non-CTCL 
dermatosis controls showed no evidence that positive 
PCR tests resulted fron"l san"lple mislabeling, gross 
HTL V -I contamination, or human endogenous retro-
viruses. We then modified the standard PCR assay to 
incorporate ultraviolet (UV) light to destroy low-
level PCR contamination. With this modified assay 
(sensitivity> 10-5), only three of 12 previously posi-
tive cases were still positive, suggesting that the 
earlier positives were due to trace contamination of 
PCR reagents or trace contamination of sample 
H uman T -celll ymphotrophic virus type] (HTLV-I) is a retrovirus whose RN A genome is approxi-mately 9 kb long and consists of group antigen (gag), po lymerase (po l), en velope (env) , and tax i rex (pX) regions flanked by lon g termin al repeats 
(Cann and C h en, 1990) . After infectin g T cells, the virus is 
transcribed into proviral DNA that becom es clonally integra ted 
into the host genome, typi call y at a fi'equ ency of about one copy per 
ce ll. The association between HTLV-I in fection and adult T - cel l 
Manuscript rece ived Apri l 1, 1996; rev ised June 7, 1996; accepted fo r 
publication June 12, J 996 . 
Reprint reques ts to: Dr. Gary S. Wood. Dermatology Scrvicc-l ·1 G(W) , 
Veterans Aff., irs M edica l Center, 1070 I East Bou leva rd. C leveland, O H 
441.06. 
A bbreviations: ATL, adu lt T -ce ll leuke mia/ lympho ma; Ell V. endoge-
nous retrovirus; MF, mycosis fun go ides; SS, Sezary syndrome. 
DNA. This interpretation was also supported by: (i) a 
n"latch between pX and pol sequences cloned from 
one PCR-positive specimen and the MT4-positive 
control, (ii) our inability to confirm HTLV-I in any 
PCR-positive case using genomic dot blotting (sensi-
tivity > 10- 2), and (iii) negative PCR results when new 
samples from two of the remaining positive cases 
were analyzed. Finally, we used our modified UV/ 
PCR/Southern blot assay to test an additional 28 cases 
of American CTCL for pX. All of them were negative. 
Although these studies of70 cases of American CTCL 
do not exclude the possibility that another virus is 
involved in the pathogenesis of this disease, they 
provide strong evidence against a role for HTLV-I. 
Furthermore, they emphasize the need for special 
strategies to control for false-positive PCR tests 
that can result from even trace levels of contami-
nation with viral DNA. As a consequence, associa-
tions between diseases and viruses should be 
viewed skeptically if they are based primarily on 
conventional PCR data. Kc}' JIIol'ds: "'J,cosis flll/~I!oidcs/ 
PCR/vil'lIs. ] lIwcst DCl'lllato/ 107:301-307, 1996 
leukemia / lymphoma (A TL) has been well es tablish ed. ATL pa-
tients are seropositive for an tibodies directed against HTLV-I 
prote ins, and ATL tumo r cells II sually contain inta ct HTL V-I 
proviru s 1110noclonally integrated into their genomes. It is believed 
that the virus contributes to the pathogen esis of ATL by producing 
regu latory protein s, such as tax, encoded by the pX region (Canl1 
and C hen, 1990; Z hao and Giam, 1991, 1992; Hall , 1994). In 
addition to regulating proviral transcription, the tax p40 is capa ble 
of transactivating severa l promoters, such as those for adenovirus 
E3, interl eukin (lL)-2, IL- 2 receptor, granulocyte-macrophage col-
ony-stimulating facto r, c-ji)s, c-s;s, and the SV 40 enhancer. ]t is also 
capable of complexing w ith the cyclic adenosine monoph osphate-
responsive e lement binding protein, which is involved in the 
regulation of human gene expression. These effects are believed to 
cause dys regulation of human T - cel l activa tion. resu lting in a 
polyclonal proliferation from which a dominant ATL tumor clone 
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eventually e m e rges. In additi o n to AT L, H T LV-I h as been linke d 
to o the l' human diseases , includin g H TLV-I-a ssocia ted m yelopa th y 
and a typ e o f a rthri t is te rme d H T l V -I-asso c iate d chro ni c infl am-
m atory arthropath y (Ka taj ima e/ aI , 199 1). The m yelo pathy patie nts 
can a lso d evelop H TlV-I-associa te d a lveoliti s , Sj ogre n 's syn-
d rom e, and po lym yos iti s. 
R ecentl y, severa l studies h ave b een publish e d suppo rtin g a rol e 
fo r H TL V -l o r a cl osely re la te d re tro virus in th e p a thogen esis of 
c utaneo u s T-cell lympho m a (C T CL), whi ch con sis ts o f m ycosis 
fun goides (M F) and its leuke mic variant, Sezary syndro m e (SS) . In 
1987, a puta ti ve n e w retrovirus, te rme d I-IT L V -V , wa s re p o rte dl y 
iso lated fro m an Italian SS patie n t and appea re d to b e presen t in 
severa l oth e r Ita li an cases (Manza ri eI aI, 1987) . A ltho u g h thi s 
fi ndin g was n e ve r confirmed, seve ra l re po rts ill th e 1990s d escribe d 
th e d e tecti o n of H T LV-I p roviral sequen ces in a v ari abl e propor-
tio n o f CTCl cases u sin g gen o mic p o lym e ra se chain re ac tio n 
(PC R ) techniques (An agn ostopo ul os el aI, 1990 ; D etm ar ci aI, 199 '1; 
Hall eI aI , 1 99 1; Z u ck e r- Franklin ci aI , 1 991; Goldman el aI, 1992; 
SI'ivasta va ct aI , 1992; Z u c k e r- Franklin el aI, 1992; 1-1 all , 1993; 
Pa n ca k e and Z u ck e r-Franklin, 1993; Whittak e r and Luzzat to, 
1 993 ; G h osh ct ai, 1994 ; MallCa el aI , 1994; Pan cake e( aI, 1995 ). 
T h e pe rcenta ge o f PC R-positive cases ran ged from 7% to 92')lu and 
included patie n ts from the U .S .A ., Sw e d en , E n g land , It aly, and 
Iran . In som e studi es, additio nal evide n ce supporting retroviral 
infecti o n was o bta in ed b y e lectron mi croscop y (M an za ri el aI, 1987; 
H a ll el aI , 199 1 ; Z u c ke r-Franklin ci aI , 199 1 , 1 992; Pan ca ke and 
Z u ck e r-Franklin , 1 993 ; Pan cak e e/ (II , 1 995), nucleo tide sequen cin g 
( H all c/ aI , 1991; Srivasta va e/ aI, 1 992; G h osh ci aI , 1994; Pan cake 
1'1 aI, 1995), and/or the d etectio n o f reve rse tran scriptase ac ti v ity 
(M an z ari ci aI, 1 987 ; G hosh ci aI, 1994) , re tro viral mRNA (G h osh 
el aI, 1994) , re troviral p ro te in s (Zu ck er-Franklin ci aI , 199 1) , o r 
an tibo di es directed ag ainst retro viral pro te ins (G o ldman el aI , 1992; 
Kiss ('/ aI, 1992 ; Sri vasta va cl aI, 1992 ; G h osh el aI, 1994 ; Pancake el 
aI, 1 995) . In m an y PC R-positive c ases , onl y p o r t ion s o f th e 
I-1TLV -I provira l gen o m e could b e d etected . Thi s su gges ted tha t in 
con tras t to ATl, in whic h in tact H T l V -I p rov irus is typicall y 
present, CTCL m ay involve integratio n o f a t run cated o r d e le te d 
fo rm o fHT LV-1 (Hall el aI, 199 1 ; H all , 1 993, 1994) . Th e m ost 
commo n segm e nt of HTL V -I d e tec te d in these studies has b een th e 
pX regio n , which contains t he tax and rex gen es (Ca nn and C h en , 
1990). T hi s has le d to speculati o n that th ese regulato ry gen es are 
in volved in th e p a tllOgen es is o f CTCL (H all ci aI, 1 991; H all , 1993 , 
1 994; G h osh ci aI, 1994; Pancak e 1'1 nl , 1995) . 
Tn contrast to th ese re p o rts. other recent studi es involving simila r 
PC R m e tho d s h ave n o t d e tec te d evide n ce o f l-ITLV-I o r rel a te d 
retroviruse s in CTCL cases from th e U .S. A ., Scandinavia, France, 
P o r tu g al , Germ an y, o r S witzerland (Lisb y et aI , 1992; Baza rbac h.i ci 
aI, 1 993 ; B o ni el aI , 1996; Li eI aI, 1996). T hi s su gges ted a p oss ibl e 
geographic cluste ring o f H T lV-I+ and H T LV-I - CTCl cases 
anal ogou s to that of Burkitt's lymphoma , w hic h ex hibits a h.i g h o r 
lo w d egr ee of associa tio n with E p ste in-Barr vim s d e p e ndin g on the 
geographic orig in o f th e cases (Ba z arbac hi cl aI, 1993; Hall , 1993 ). 
N evertheless , th e di sp ara te results of recen t studies have gen erated 
controversy con cerning th e ro le o f H TLV-I in CTCL. To expl o re 
thi s issu e fur th e r , w e pe r fo rme d a deta ile d m o lecular bio logic study 
of 70 cases of Am e rican CTCL. 
MATERI ALS AND METH O DS 
Specimens All tissue specimens were obtained acco rd ing to procedures 
that had Human Subjects Committee approva l. All di agnoses were estab-
lis hed using standa rd cl inicopa tho logic criteria (Wood, 1992). Deta il s 
concerning the type of TCl (M F "C/'S II S SS) , stage of di seasc, type of lesio l1 
sa mpled. and geographic origin arc in cl uded in T able I. N on-CTC L 
con tro ls were les ional skin biopsy specimens o btained from the fo llow ing 20 
O hio cases: ten squamo us ce ll ca rcinoma w ith T -cell infiltrates, fo ur 
cuta neous lymphoid hyperplas ia, two pso ri asis, and one each of pi tyriasis 
ntbra p il ari s. ch ronic spongio ti c de rmati tis, licheno id drug eruprion. and 
granuloma annulare. T he HT LV -1- T -cell line, Jurkat, and carryover tu bes 
conta inin g all reagents except ta rget D N A served as negati ve colltro ls. T he 
I-IT LV-I ' T-ce ll line, MT4, se rved as a positive control. Genomic DNA 
T H E J OURNA L OF INVESTIGAT IVE DERM ATOLOGY 
Table I. Clinicopa thologic and Geographic 
Characteristics of 70 Alnerica n C T CL Cases" 
TNM Stage 
Location" MFISS II III IV 
O H 26/4 P (1(,) P(l ),T(4) P (1 0), B (1) 
CA 15/2 P ( 13) T (1) E (2) P (1) 
MI 10/3 P (2) P (2) . T (1) P (3), T (2). B (3 ) 
M A 5/0 P (5 ) 
MI SC 3/2 P (I)' P ( I)" E (2)" T ( I)" 
" B. le ukemic hlond: E. cryt'h rodcrl lI ;I: M F = mycosis fi. lI1 goidcs: J). prt tch / plaque: 
SS . Sczary synd ro l1l c; T, tUIll Or. 
/, I' i/'Sl ,orics o r '12 CT CL C "ses: O hi o (2M), C" li ro l'l1ia (5). Ma ssa" hu,e'" (5) . Alaska 
(1). Norlh Caro lina ( I ). Pcnn ,),Ivania ( I). U tah ( I). Second 'o ries o f 2R T C L cases: 
Michigan ( 13). C ali fol'l1ia (12) . O hio (2) . Pcnn,ylvania ( I). 
/" Pc nnsy lvan iil . 
" North C;l ro lill a: Ura h . 
" Alaska. 
was ex tracted from all specimens using standard techniques (S;unbrook ei af. 
1989). 
T he T-ce ll density o f each case was assessed usin g single-label illlllluno-
peroxidase methods (Wood and W arnke, 19H2) and monoclonal antibodies 
specific Fo r pan- T-cell and T-ce ll subset an tigens (C D3, C D 4, CD8). The 
T -cell DNA content o f the spec imens was then es timated immunohisto log_ 
ica ll y using standards desc ribed prev io usly (\l(Iood ('/ nl, 1991) . Patch lesions 
contaiJled at least 1 O'y., T-ce ll DNA . O ther types of les ions con tained at least 
25% T-cell DN A. In addition, Illos t cases were subjected to analys is of 
T-cell receptor-y gene rea rrangements using the PC RJ denaturiJlg gradient 
gel electrophoresis techn.ique. as repo rted prev io usly (W ood Ci nl. 1994). All 
cases tested had di stinct domin;lIl t cl onal bands of an intensi ty tha t indicated 
a CTCL tumor clone density greater than 1 % in all cases and grea ter than 
10o/cl ill ITl ost cases. In a 1l1ino rity o f cases , turn Qr clone density in excess of 
10% was al so confirmed by demonstnltion of intense clonal T-ce ll recep-
tor-{3 gene rearrangements using genomic Southern blot analysis, as 
described previo usly (W ood ('/ nl, 1988) . T hese iml1lunogeno ly pic assays 
also se rved to control fo r the integri ty of the les ional DNA ex tracts. 
peR Using pX, pol, and env Prilners PC R reactions w ere perfo nlled 
according to standard methods (Erli ch , 1989). O ligonucleo tide primers 
we re as fo ll ows : ups tream pX (bp 7596-7617. 5' -CCAAT CACTCATA-
CAACCCCCA-3'), do wnstrea m pX (bp 7722-7701, 5' - CTGGAAAA_ 
GACAGGGTTGTTGGGAG-3' ) (I-I all cl nl, 199 1); upstream po l (bp 
3365- 3384. 5'-CT TCACAGTCTCTACT GT GC-3'). downs tream pol (bp 
3483-3465 , 5' -CGGCAGT TCTGTG ACAGGG-3' ) (Kwok ('/ nl, 1988): 
and ups tream env (bp 5233-5253. S'-TCTTCCAGTTCTGCCCCCTCA-
3') , downstrea m env (bp 59 19-5899 . 5'-GGACGT GeCAAGTGGAT-
AGGC-3'). Th e env primers were des igned by us. All three primer se ts are 
complementary to HT LV-I sequences, bu t not to I-IT LV-II sequences. The 
buffer used fo r the pX PC R was 50 mM Kel, 10 mM T ri s e l (pH 8.0). 0._ 
111M of each dNT P, and 1.0 mM MgCI2 in ste ril e type I H 20 . Each reaction 
mixture had a tota l volume of 50 ,.d , which conta ined 35 ,.d pX buffer, 20 
pmol each of upstream and downstream primer, 2 .5 U AllIplitaq DNA 
Polymerase (Perkin-Elmer. R oche Molecular Systems, Inc., I3ranchburg. 
NJ ). 2 ILg template D NA, and ste ril e ty pe I 1-1 2 0 . T he re:lcti ons were 
perfo rmed in a DNA T hermal Cycle r 4HO (Perkin-Elmer, Norwalk , CT) . 
T hermal cycling consisted of30 cycl es , with I min dena tur:ltion ;It 94 °C , 1.5 
min annealing at 56°C for pX and envoI' at 49°C for pol. and 2.0 min 
extension at 72°C. As deta iled in R eSH/ls, another step was added to dlis 
conveJl tional PCR protocol during [he stud y to achieve enhanced control 
over PCR cross- contamina tion . Befo re the templa te DNA and AmpLitaq 
DNA Polymerase wcre added to the reaction mixture, the pCR buffer and 
primers along with the steril e type I 1-12 0 and overla y mineral oil were 
exposed to 254 nm and 307-3 12 nm ul tra vio let Li ght for 20 min (Sa rka r and 
Sommer, '1990). In each assay, contro ls included MT4 (HTLV-I +). J u rkar 
(HT LV-I - ), and carryove r (all reagents except target D N A). Addi tional 
contro ls were also used as detail ed in R eslIlls. 
Southern Blot Analysis ofPCR Products U sing Nested Oligonucle-
otide Probes According to standard methods (Salll brook el nl, 1989). 
IO-JLI aliquors of each reaction were electro pho resed on a 0.8% aga rose gel 
at 100 V and transfe rred on to a nylon membrane using a Vacugene transfer 
apparatu s (Charles Austen Pumps Ltd ., ByAeet, UK ). After transfer, the 
mem brane was auto- cross-linked in a Strat. linker (Stratagene Cloning 
Systems, La J o ll a, C Al and then was hed in 4 X sodium citrate/sodium 
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c hlo ride buffer (SSC). T he membrane was p rehybridized, hybrid ized using 
nested o ligonucleo tide pro bes . ,md then incubated at S5 °C on a rocker for 
24 h . After hybridization , the membrane was washed with 2 X SSC/O. IOX, 
sodium dodecyl sul fate (SDS) at room tempera ture for 5 min , 2 X 
SSC/0.1% SDS at room temperature fo r 15 min . and O.S X SSC/O. l % SDS 
in a 37°C shaker bath for 30 rnin. The membrane was placed into an x-ray 
cassette with in tensify ing sc reens and fi lm , and then placed in to an 80°C 
freeze r for 17 h . N ested o ligonucleo tide probes were as fo llows: pX (bp 
7700 - 7671, 5' -GTGCTGCCCAAGGGTGGGTTCCA TGTATCC-3 ') 
(Hall et ai, 1991), po l (bp 3460-3426, 5' -CCGCAGCTG CACTAATGAT-
TGAACTTGAGAAGGAT-3' ) (Kwok CI ai, 1988), and env (bp 5594 - 5560, 
5' - GGGGCTGGAGACGGCTCCTGT ATAGGGGCAGGTCC-3'). T he 
latte r probe was designed by us. 
D ot Blot Analysis Using HTL V -I Proviral Clone A dot blot manifo ld 
apparatus (Schle icher & Schuc Il , Keene, NI-I) was used fo r this procedure 
accordi.ng to standard methods (Silmbrook et ai , 1989) . Before assembling 
the manifo ld and attaching the vacuum line, we moistened both the blotte r 
paper and nylon membrane with de ioni zed H 20 . Each designated well was 
loaded with 500 I.d 4 X SSe, 10 J.Lg DNA , 500 J.LI denatura tio n so lu tion, 500 
J.LI n eutrali zation so lu tio n, and 500 J.LI 20 X SSC. Between each so lu tio n and 
the DNA, the vacuum was app lied un ti l transferred thro ugh. The mem-
brane was then auto-cross-linked and washed as described previously. T he 
membrane was prehyb ridi zed and then hybridized with " radiolabelcd 
8.5- kb I-ITLV-I fragment , 25 ng DNA (obtained from Dr. C ho ll-Zen Giam. 
Case Western R.ese rve U niversity, C leveland. O H). acco rd ing to the 
protocol in the GIBCO BRl.. (Gaithersburg, MD) RadPrimer Labeling 
System (Cat. no. 18528 - 011). Afte r hybridization, the membrane was 
washed for 5 min at room te m perature with 2 X SSC/O .·I 'X, SDS, 'I () min at 
room temperature with 2 X SSC/O. l % SDS, and 30 min with 0. 1 X 
SSC/O. l % SDS at 60°C. T he membrane waS exposed to x-ray fi lm ll sing 
i.ntensifying sc reens for 7 d in a -SO°C fi·eezer. 
Genomic Southern Blot Analysis Using HTLV-I Proviral C lone 
Ten micrograms o f each EcoRJ-digested DNA sample in a volume of 15 I.d 
plus 15 J.LI of2 X loading buirer was electropho resed on a 0.8% agarose ge l 
tha t had been run at 40 V overnight. T he e lectrophoresed DNA was then 
transferred o n to a n ylo n Ine rnbr;tnc. auto-crass-linked, and 'washed as 
described previously. T he membrane was prehybridized and then hybrid-
ized at 42°C for 24 h with 25 ng orthe same radio labeled 8.5-kb HTLV-I 
probe as described eaTlier:. T he membrane was washed and auto rad io-
graphed as described in the preceding section. 
DNA Cloning and Sequencing PC R products were ligated into the 
pCRlI vector (Invitrogen Corp ., San Diego. CAl based on overhanging 
A -T hybrid ization alld were propagated in Escherichia coli. C loned DNA was 
recove red from se lected colonies using standard methods (Sam brook ct ai, 
1989). Sequencing of cloned PC R. products was perfo rmed using the 
dideoxy method of Sanger (Sam brook CI " I, 1989) and a computerized 
Pharm3cia ALF auto mated nucleotide sequencer (Pharmacia Biotech, Inc., 
Piscataway, NJ). 
DIS80 PCR Analysis To control for specimen mislabeling and gross 
contamination , samples tha t ini tia ll y screened pos itive for I-ITL V -I were 
subjected to ,ulal ys is of 01 S80 polymorph.i sms (Kasai el ai, 1990) using the 
D 1S80 kit (Perkin Elm er Cetus, R oche Mo lecular Systems. In c., Branch-
burg, NJ) accord ing to the manu [;,cturer's directions. 
Sensitivity Calculations C alculations concerning the sensiti vity of var-
ious methods ll sed in this study were based on the fo llowing rela tions: (i) 
1-1 .5 X 105 ce lI s yield I J.Lg o f DNA (Kwok et ai, 1988; Aster et nl. 1992 ): 
and (ii) each MT4 cell contains approximate ly five copies of HT LV-I 
provirus, as determined by Southern blot anal ys is of EcolU-digested 
genomic DNA probed with our 8.S-kb HTLV-I proviral clone. T he 
PCR-based assays had a sensiti vity o f at least 10- 5 for MT4 DNA di lu ted in 
tonsil DNA and 10- 6 !-o r MT4 DNA di luted in buffer. Based on these 
relations and titration studies involving the MT4 positive contro l, we 
determined that this equaled two to three MT4 ce ll s (10-15 HTLV-I 
copies) and less than one MT4 ce ll (one to twO HT LV-I copies) pe r PC R. 
reaction, respective ly. In one titration experiment involving MT4 DN A 
diluted in tons il D NA , the pX PCR product was detected down to 10- 5 and 
tben again at 10- ", a titer at which the re would be no more than one copy 
of targe t DNA per tube. T his indicates the extreme sensitivity that is 
sometimes achievable using PC lt methods to detect fo reign DNA . T he 
non-PC R-based dot blot assay had a sensiti vity of at least 0.5% (i.e ., better 
than 10- 2 ) for MT4 DNA dilu ted in tonsil DNA. 
R ES ULTS 
A Minority ofCTCL Cases Exhibit HTLV-I Positivity Using 
Conventional PCRJSoutbern Blot Analysis To searc h for 
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Figure 1. HTLV-I pX proviral DNA was detected in seven of 42 
CTCL cases using conventional PCR/Southern blot a n alysis . T he 
126-bp pX PC R product was detected in the MT4 positive contro l and in 
fo ur of nine CTC L cases (M F) shown here, bu t not in the Jurkat T -ceI l li ne 
negative controls OU R) o r the carryover negative control lacking target 
DNA (CO). 
HTLV-I provira l DNA sequ e n ces in CTCL. we subjected Ies iona l 
bio psy sp ecimen s obtained fi'o m 42 A m erican CTCL cases to 
genom ic PCR analys is, fo ll owed by confirmato ry Southern b lot 
anal ys is u sing n es ted oligonucl eotide probes. T h ese in c lu d ed 28 
from O hio, five fi'om Ca lifo rnia, fi ve fi'o l11 M assac hu setts. and olle 
each fi:om A lask a, N o rth Carolina, Pennsylvania , and Utah (Table 
I) . W e tested for pX, p o l, and e ll v sequen ces as deta il ed in Ma terials 
alld Metliods. N ega tive con trols include d th e JlII'ka t T - cell line and 
carryover tubes con ta ining all PCR reagents except target DNA. As 
re ported pre vio u sly b y oth ers, a va riab le propo r tion of PC R tests 
were positive: seven of 42 for pX, three of 42 for pol, and two of 
37 for en v , resulting in an over all PCR- pos itive test rate of 12 of 
121 (10%). All positiv e res ults were reprod u cible in at least o n e 
separate experim e n t. Among indi vidual c ases. th e positive PCR. 
resu lts produced th e fo llowin g gen otypes: 32 pX - pol - e n v - , five 
pX + pol - e n v - , two pX + pol l- env - , two p X - pol - e ll v + , and one 
pX - p o l+ e n v - . Rep resentative findings are illu strated in Figs 1 and 
2. 
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Figure 2. HTLV-I pol proviral DNA was d etected in three of 42 
CTCL cases using conventional PCR/Southen, blot analysis. The 
119-bp pol PCR product was detected in the MT4 positive contro l and in 
two of eigh t CTCL cases (MF) shown here, b ut not i11 theJ urkat T-cell linc 
negati ve contro l OUR) or the canyover negative 'ontro l lacki ng target 
DNA (CO). 
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Additional Studies Indicate That Trace Contamination Ac-
c ounts for the PCR-Positiv e Cases T he lack of consisten t 
detecti on of specifi c proviral sequences w as not un expected , 
because thi s ph enom eno n has been observed in seve ral pl·evio us 
studies (Hall ct a/ , 1991; Z ucke r-Franklin el a/, 199 1, 1992; 
Goldman e/ a/, 1992, Srivastava et a/, 1992 ; H all , 1993; Pancake and 
Z ucker-Franklin , 1993 ; Whittaker and Luzzatto , 1993; G hosh c/ a/, 
1994; Manca et a/, 199 4; Pancake ct a/, 1995) . It has led to the 
h ypothesis that CTCL may be induced by the integratio n o f 
truncated o r partially deleted H TL V -l o r H T LV -I-like proviral 
D N A into the T -ce ll population fro m which the CTCL tum o r 
cl o ne eventuall y em erges (Hall et a/ , 1991; H all , 1993, 1994) . 
N evertheless , certain charac teris tics o f o ur positive PC R results 
were unexpected . First, onl y two of ten cases were positi ve for 
m o re th an o ne proviral gene segmen t , and no ne w ere positive fo r 
a ll three segm ents tes ted . Second, three of ten cases lacked 
detectable pX-the proviral gene segm ent hypo thesized to be 
responsibl e for the o ncogenic e ffects of HTL V -I (Cann and C hen , 
1990; Ha ll et a/, 1991; Z ha o and Giam, 199 1, 1992; H all, 1993, 
1994; Ghosh et a/, 1994; Pancake el at , 1995). As a consequ ence of 
these o bserva ti ons, w e compl eted a sel·ies of experiments d esigned 
to determin e the sib'11i fica nce of o ur positive PCR results. 
First, we confirm ed the specificity o f o ur PC R /Southem blo t 
m ethod for I-ITLV-I sequ ences by clo nin g and sequencing the PC R 
products amplified fro m the MT4 positive control ceU line. T he 
PCR produ cts were confi rmed to be H T LV-I sequ ences. T he MT4 
pX and po l seq uences w ere consistent in mul tipl e experimen ts and 
m atched those o f a prototypic H TLV-I strain kn own as ATLV. 
Several slightl y differen t MT4 env sequ ences were de tec ted amon g 
diffe rent expel;ments, and each m atched th e proto typic H TL V-I 
strain except fo r a few bp . T hese slight d ifferences probably were 
deri ved £r·om the multiple copi es ofH TL V -I pro virus that appear to 
be clonally integrated in to MT4 cells (sec Materia/s alld M et/lOds) . 
Second , we used PC R analys is o f D 1 S80 pol ym o rphi sm s to 
excl ude mislabeling and gross contaminatio n of DN A ex tracts. 
0 1 S80 is a highly polym Ot-phic, human geno mic locus containin g a 
variable number of tandem repea ts. T he 29 kno wn alle les deter-
mine 435 possible genotypes and pro vide a discriminatio n power of 
m o re than 95% am o ng different indi viduals (Kasai el a/, 1990). PC R. 
analys is of the D1 S80 locus sho wed that the H TLV-I + CTCL 
specimens were not mislabeled MT4 positi ve controls or gross ly 
contaminated with MT4 DNA beca use the MT4 D1 S80 PC R 
products exhibi ted a unique patte rn no t seen in the CTCL speci-
m ens. T his assay re ljably excl udes con tamin atio n o f 10'1., o r m o re 
(Cosso and R.eyno lds, 1995). R epresentative results arc shown in 
F ig 3 . 
T hird , we rul ed o ut the detection of human endogeno us re tro-
viruses (ER V s) and rela ted geno mes. T ho usa nds of these sequences 
are known to be presen t in human DN A (Repaske ct a/, 1985; 
Ma ger and Freem an , 1987; Cohen and Larsson, 1988; He hlm 3nn et 
a/, 1988; Larsson et ai , 1989; An te l and Cashman , 1991; Prayoon-
wiwat et a/ , 1991; Krieg et a/, 1992; Leib-M osch el a/ , 1992; 
Medstrand ef a/, 1992; T ing cl ai, 1992; Andersson et (1/ , 1996) ; one 
is kn o wn to exhibit about 60% nucleo tide sequence homo logy with 
po rtio ns of HTL V - I and H TLV -II gag genes, and ano ther has 
signifi can t hom o logy to the B T L V -1 p o l gene (Mager and Free-
m an , 1987; Fujihara et a/ , 1994) . T he HTLV-l- Jurkat cell lin e, 
in cluded as a negati ve control in all experiments, is a relatively 
good con tro l fo r ER V cross-reactivi ty because m ost ER Vs are 
beli eved to have been incorporated into the human genom e 
su fflc iently lo ng ago to be shared tn comm on among aLI individu als. 
N everthe less, to expl ore the po ssibility of a more recently in te-
grated o r polym orphic ER V (Antel and C ashman , 1991; Kd eg et a/, 
1992) as the so urce of positive PC R results, we screened les ional 
D N A from several non-CTCL dermatoses (see M ateria/s alld Meth-
ods) for H T L V - I sequences, including 20 cases for pX, 17 for pol, 
and ten fo r env . All were unifo rmly nega tive using PC R / So uthern 
blo t analys is. 
Fourth , beca use our con ven tional PC R m etho d w as so sensitive 
fo r detectin g HT L V -I , we m odi fie d it to minirnize furth er the 
A 
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Figure 3. PCR analysis of DIS80 polymorphism. excluded gross 
contamination in CTCL cases that were HTLV-I+ by conventional 
PCR/Southern blot analysis. 0 1S80 PCR products showed no evidence 
that CTCL specimens (MF) were grossly contaminated (2 10'%) with MT4 
positive control DNA because the MT4 Dl S80 PCR products exhibited a 
unique pa ttern not seen in other lanes. 0 1S80 allelic ladders (A L). positiVe 
control (PC), and negative carryover contro l (CO) arc also shown. 
chan ces o f trace contaminatio n with HT LV- I D NA. As detailed in 
M ateria/s alld Methods, w e added a step tha t uses ul travio let (UV) 
light to des troy all sources of viral DN A contaminati on except 
th ose presen t in the T a'1 DN A po lym erase o r the target DNA itself 
(Sarkar and So mmer, 1990) . U sin g this m ethod , which has a 
sensiti vity th resho ld simi.iar to that of o ur con ven tio nal PCR assay 
(> 10 - 5 , see ea rlier) , we repea ted the ini tiall y positive PCR tests. 
O nly three of 12 were still positive, sugges ting that m ost of the 
initial PC R positives were due to trace contamin ation of PCR 
reagen ts, whereas the remainin g three were probabl y du e to trace 
con tamin ation o f sample DNA . T his in terpretatio n was supported 
by three additio nal lines of ev idence, as foUo w s. 
First, the pX and pol sequences clo ned fi·o m one of the ini tially 
positi ve cases matched MT4 sequences exactl y. Furthermore, w hen 
retested using the UV / PC R /Southern bl o t m etho d , this case was 
nega ti ve. Second, we were unable to con fi rm th e presence of 
H T LV-I proviral DNA in any of th e initially P C R-positive cases by 
dot blo t or So uthern blot analys is o f geno mic DN A using a 
full-l ength 8.5-kb H TLV-I clone as probe . R epresen tative findings 
are illustrated in Fig 4. T he sensitivity of th e dot blo t assay (0.5%) 
is considerably less than that o f OLlr PCR assays; ho wever, ro utine 
histo patho logy, immunopermdda se analys is o f T - cell m arkers , 
and/or PC R /denatut;ng gradient gel electrophoresis analys is of 
T -cell c10nali ty had indica ted at leas t thi s d ensity of CTCL tumor 
ceUs in a ll cases tested. T here fo re . these nega tive results also 
suppo rted trace contaminatio n as the m ost likely explanation for 
the initially positive PC R. resul ts. Fin ally, w hen compl etely ne\y 
biopsy specimens were obtained fro m two of the rem ain in g three 
PC R - positive cases, bo th tes ted nega tive for their forme rly positive 
HTLV-I genes . Bo th specimens were obtain ed fro m active CTCL 
lesions clinicopatho logically similar to the o riginal biopsy speci-
mens. T his makes it unlikely tha t sa mpling error accounted fo r the 
negati ve results. 
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Figure 4. Genomic dot blot analysis does not confirm HTLV-I in 
CTCL cases that were positive by conventional PCR/Southern blot 
analysis. The MT4 positive control (box H1) was positive; however, CTCL 
cases (MF; boxes D6, F6, iltld H6) were negative. as well as the Jurkat T-cell 
line negative control OUR). Hodgkin's disease (HD) , reactive tonsil 
(TO N), normal skin (NS). and CD30 + large ce ll lymphoma of T-cell 
I;neage (LCL). The other boxes arc blank. The probe was a radiolabeled. 
8.5-kb fu B-length HTLV-I proviral clone. 
No HTLV-I pX Is Detectable in CTCL Cases Using UVI 
peR/Southern Blot Analysis We next collected an additiona1 
series of28 American CTCL cases, including 13 from Michigan, 12 
from California, two from Ohio, and one from Pennsylvania 
(Table I). W e screened them for the pX region using our 
UV IPCRlSouthern blot method . Thjs HTL V-I segment was se-
lected because it is the one that was detected most commonly in our 
first group of cases and in previous studies, as well as the one most 
likely to be capable of inducing neoplastic transformation (Cann 
and Chen, 1990; Hall el ai, 1991; Zhao and Giam, 1991, 1992; Hall, 
1993, 1994; Ghosh ef ai, 1994; Pancake and Zucker-Frank1in, 
1995). All 28 cases were uniformly negative. Representative find-
ings are illustrated in Fig 5. 
DISCUSSION 
T he results of our analysis do not support a role for HTL V -I in the 
pathogenesis of CTCL in the U.S.A. Our findings in 70 American 
cases w ere consistent with our previous studies showing no evi-
dence of HTLV-I pX. pol, o r env proviral DNA in 50 cases of 
German and Swiss CTCL (Boni el nl, 1996) . T hese findings were 
+126 bp 
MMMMMMMMMMMJ BC BBB BM 
FFFFFFFFFFF U () T 
R 4 
Figure S. HTLV-I pX proviral DNA was not detectable in any of28 
CTCL cases using UVIPCR/Southern blot analysis. The 1 26-bp pX 
PCR product was detectcd in the MT4 positive control but not in CTCL 
cases (MF), the Jurkat ncgative control (JUR). carryover negative control 
(CO). or blank lanes (8) . 
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also consistent with our study of 35 cases of CTCL-associated 
disorders, includi.ng CD30 + large cell lymph oma, lympho matoid 
pap ulosis, and Hodgkin's disease. ' Among these cases. we were 
unable to dem o nstrate evidence of HTL V -I proviral integration by 
pX PCRISouthem blot analysis, genomic dot blotting, or Southern 
blotting of EcoRl-digested genomic DNA probed with the same 
full-l ength 8. 5-kb HTLV-I proviral clone used in the current study. 
Tn aggregate, these three studies showed no convincing evidence of 
HTL V -I proviral integration in lesional sampl es from 155 cases of 
CTCL and associated disorde rs obtained /Tom several countries, 
including seronegative cases from an HTLV-I- endemic region of 
Japan . 
In addition to their geographic diversity. our CTCL cases 
included both M F and SS; patients spann ed every stage of disease (I 
through TV) ; specimens were obtained from every type of skin 
lesion (patch, plaque, tumor, erythroderm a); and samples included 
leukemic blood as w ell as skin. Therefore, it is unLikely that our 
negative results can be attributed to som e form of sampling error 
involving type of CTCL. stage of disease, type of skin les ion, o r 
type of tissue studied . 
Furthermore . all samples were obtained from tissues that were 
morphologicall y diagnostic ofCTCL, and the majori ty were shown 
by immunogenotyping to contain tumor cell densities more than 
adequate for the detection of HTL V -I provirus by PCR or genomic 
DNA hybridization, even ifonly one copy ofHTLV-1 were presen t 
in each tumor cell. Tumor cell densiti es were adeq uate because 
each case tested contained a readily detectable clona.! T-ce ll recep-
tor gene rearrangement that is typically present at a density of one 
copy per cell. Therefore, inadequate tumor cell density cannot 
account for the lack of detectable HTLV-I provirus in o ur cases. In 
f.1Ct, the abiljty of our PCR methods to detect even a sm all number 
of copies ofHTL V -I DNA per PCR reaction indica tes that the virus 
would have been detected even if it were present in a cell 
population other than the CTCL tumor clone, e.g., reactive T cells, 
B cells, or Langerhans cells. 
We designed our own primers and pro be for env and used 
previously published oligonucleotide sequences for pX and pol 
(Kwok cl ai, 1988; Hall c/ ai, 199 1) . AU showed appropriate 
sensitivity and specificity. Tn particular, the pX primers have been 
used in several studies of CTCL and ha ve reportedly shown 
positivity in some cases (e.g., Hall el ai, 1991; Hall 1993. 1994) . In 
addition, w e have used these primers successfully to detect HTLV-1 
in the MT4 cell line and in 100% of A TL cases tested (Wood e/ ai, 
in press). T here fore, our negative pX findin gs in the current study 
are not due to the use of suboptimal primers, probes, o r methods. 
Our findings are ill agreement with those of three other PCR.-
based studies of CTCL involving patien ts from the U.S.A. , Scan-
dinavia. France, and Portugal (Lisby ct ai, 1992; Bazarbachi et ai, 
1993; Li el ai, 1996). None of these studies provided support for a 
pathogenetic association between HTLV-I and CTCL. In contrast 
to these essentially negative studies, other groups have reported 
evidence of HTL V -I or HTLV -I-related proviral integration in 
CTCL based on a combination of molecular biologic, ultrastruc-
tural, and serologic findin gs (Anagnostopoulos el ai, 1990; Dctmar 
cl ai, 199 1; H all el ai, 199 1; Z ucker-Frank1itl el ai, 199 1. 1992; 
Goldman et ai, 1992, Kiss ct ai, 1992; Srivastava ct ai, 1992; Hall. 
1993; Pancake and Zucker-Franklin, 1993 ; Whjttaker and Luz-
zatto, 1993; Ghosh el ai, 1994; Man ca cl ai, 1994; Pancake el al. 
1995) . The geographic origins of these cases include N ew York. 
Pennsylvania, England , Sweden, Iran. Italy, and Hungary . How ca n 
these apparently contradjctory findings be resolved? The possibili ty 
that HTLV-I is associated with CTCL o nly in specific geographic 
locations cannot be excluded, but appears highly unlikely given the 
relatively wide geographic diversity of the cases in which no 
HTL V -I has been detectable. More likely in o ur es timation are the 
I Wood GS. Schaffer JM . BOlli R , Dummer R , Burg G. Takcsh;ta M, 
Kikuchi M: No evidence of HTLV-J prov;raJ integration ill Iymphoprolif-
crativc diso rd c r~ associated \vith cu taneoll s T-cell Jynlphoilla. J I IIIJt:st 
O ef/llato/ 106:914. ·1996 (abstr.). 
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fo ll owing possibiljties: (i) misdiagnosis of some chronic cases of 
ATL as CTCL, (ii ) coincide ntal infection of some CTCL patients 
wi th HTL V - I, (iii) artifacts due to contaminatio n of CTCL speci-
mens Or cell cultures with HTLV-I o r re lated retroviruses, and (iv) 
detection of ERVs or exogeno us viruses related to, but di stin ct 
from,I:-ITLV-l. 
Evidence for the first two possibilities can be found in reports 
involving cases frOIll New York C ity, western N ew York state, and 
Jran (Anagnostopo ul os et nl , 1990; Detmar d nl, 1991; Goldrnan ct 
nl , 1992; P;lJ1cake cJ nl, 1995). Am ong the patients in each of these 
studies were some who were p ositive for I:-ITLV-I / JI antibodies 
using standard serologic m eth o ds. This is a clear indicatio n that 
these patients were infected with HTLV (Cann and C hen , 1990) . 
T he T-cell lymphomas in these cases co uld have been coincidental 
CTCL. Alternativc!y, it is poss ibl e that these patients actually 
sulfered £i'01ll variants of HTLV- I-associated ATL that were mjs-
diagn osed as CTCL. In addi tion to the well-described fu lll1imll1t 
form of ATL. there are several more indo lent variants of this 
disease. includin g pre- A TL. smoldering A T L. and chronic A TL, 
which might be confused c\.inica lly and patho logica ll y with val·ioLls 
forms ofCTCl (Cann and C hen, 1990; DiCaudo ef nl, 1996) . 
It is noteworthy that the CTCl stu dies in which H TLV-I was 
detected by PC R used o nly standard contro ls fo r contamination , 
such as p lu gged pipette tips. carryover contro ls, and I:-IT LV-] -
D NA controls. As we have shown in this study, the extrem e 
sensitivity of PC R meth ods for detectin g viral DNA in human 
ti ssues n ecessitates the use of special strategies, su ch as those 
in volving UV irradiation (Sa rkar and Sommer , 1990) o r uracil-N-
glycosylase (Longo et nl, 1990), to minimize the risk o f fa lse-
positive results du e to trace contamination of PC R reagents. 
Ca reful handling of specimens be fo re and during DN A extraction is 
also criti cal for avoiding contamination o f the stock DNA itself. For 
example, ti ssue blocks h andled with the same utensils or cut with 
the same mi crotome knife ca n be cross-contamin ated to an extent 
detectable by PC R . Furthermore. in th ose stu di es involving cul-
tured cells, consideration sho uld be given to in fection of o ne 
patient's ce lls ill vitro by virus derived from ano ther pati ent's cells, 
positive co ntrol cell lines, o r even ceU culture reagents such as feta l 
bovine serulU , which some times contains bovine viruses (DoLlr-
m askin et nl, 1993; Lessin et nl, 1994). 
Detection of Ell.. Vs or exogenous viruses related to H Tl V-I is 
an o ther possibility. R ecent studies have de l1l onstr,lted that human 
DNA contains thousands of ER V sequen ces, includin g full- length 
(8.8-kb) genomes, truncated (4.1-kb) gag-pol segments, and iso-
lated lon g terminal repeat regions (Repaske et ai , 1985). ERVs 
represent at ·Ieas t O.1-0.6'X, of the human genome and consist of 
m ore than a dozen diffe rent fa milies, w ith the copy number per 
fa mily ran ging fro m on e to 30,000 (Leib-Mosch et nl , 1992). 
Although a\l ER V s analyzed thus far h ave been defective and 
in capable of en coding competent re trovi ral particles, some have 
considerable sequence horno logy to HTl V genes such as gag and 
pol (Mager and Freeman , 1987; Fujihara ct ai, 1994) . Beca use 
d iffe rent PCR-based studies have used diffe rent HT l V -I prim er 
sequen ces, it is possibl e that some HTl V -I primers would detect 
ERVs m ore readi ly tban oth ers. N on-CTCL controls would not 
necessarily I'ul e o ut in advertent de tec tion of ER V s if the ER V s 
were polymorphic (Krieg et nl. 1992) or if rJlCy were different 
enough from H TL V -I. thM they amplifi ed very in effi ciently using 
H TL V -I primers. 
Some ER Vs can res ul t in the assembly of particles reselllbljng 
retroviruses ultras truc turally, especia lly C-type p~rticles. For exam-
ple, such struc tures, as well as re verse transCl'iptase ,Ic tivi ty and 
certain gag antigens, have been observed in the majority of normal 
human placenta s (Larsson el nl, 1989) . In addition to containjllg 
potentiaUy cross-reactive PCR. targets and en coding ultrastructur-
ally visibl e virus-like particles, EK V products could conceivably be 
the antigellS responsible for circulating antibo dies that might cross-
react with H TLV proteins (Antel and Cashman, 1991). For exam-
pl e. an endogenous retrovirus known as ER V3 is capable of 
encoding an env prote in transcript in several hurnan tissues 
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(Andersson et nl, 1996), and plSE e n v and gag-related proteins have 
been detected in the scm and cells of patients with leukemia and 
autoimmune diseases (Leib-Mosch et nl, 1992). Furthermore, ex-
pression of ER V tran scrip ts has been shown to va ry among 
individuals and to be affected by lymphocyte activation, D A 
vimses, and p ossibly age-re lated loss of DNA m eth ylation (Hehl-
mann r t nl , 1988; Ante l and C ashman , 199 1; Krieg ef nl, 1992 ). Tllis 
may be relevant to the detectio n of presumed I:-ITL V -I transcripts 
and reverse tran sCI'ip tase activi ty in cytokine-activated. cultu red 
blood ce lls from CTCL patients (Manzari ('I "I, 1987; G hosh et nl. 
1994). Transcl'ipts fi'om the 4 - ·1 and HRES-1I1 ER V f.1 l11ilies have 
been de tected in several hum an T -cell le uke mia lines (Leib-Mosch 
ct nl. 1992). Murin e Ell.. V products can affect immune regulation by 
acting as mitogens and super:lntigens that shape the T-cell reper-
toire (Krieg eJ nl, 1992). 1n addition , E ll.. V transcription might aIrer 
the expression of gen es encoding h ost transcrip tio n factors and 
might result in th e synth esis o f Illo lecular mimics leading to 
auto immuni ty (Antel and Cashman, 199 1; Krieg et "I , 1992). ERVs 
also ha ve been postulated to act as Illu tagens by virtue of their 
transposon-Jike structure. w hi ch all ows th em to integrate 'lI1)"vh ere 
in the host genome, and by virtue of their multipl e copy number. 
whjch might create recombinatorin l " hot spots" (Hehlmann er 111, 
1988; Leib-Mosch et nl, 1992). 
Evidence for a novel exogeno us retrovirus h as been ob tamed 
{i'om studies of on e Hun garian SS patient using genomic Southern 
blo t ana lysis with a full-length HTLV-! probe unde r high- and 
low-stringen cy condi tio ns (Kiss e( "I, 1992). A sin gle d isease_ 
specific hybridizin g band was detected in leu kemic blood ceU 
DNA, but only under low-stringency condi tions . Th is result was 
reminiscent of earlie r observations in an Italian SS patient (Man zati 
cl nl, 1987) . Virus-like particles, reverse transcriptase activity, and 
HTlV -I-positive Southern blot ana lys is on ly under low-stringency 
conditions were observed in a B-ccl l line cultured fi:o l11 this 
patient's blood. Additional studi es will be required to detenninc the 
importancc of these findings. 
It is important to emph asize that the potential sou rces of 
fa lse-positive results for HTlV-1 discussed p rev io usly need no t be 
mutu ally excl usive and could easily exist in various combinations. 
T h ese considerarjolls do no t rul e out the poss ibility that some other 
exogenous virus, perhaps as yet undiscovered, m ay b e in volved in 
the pathogenesis of CTCL o r a subse t of CTCL. T h ey strongly 
suggest, h owever, that this potential agen t is not HTLV-\. 
H TLV-II is also an unljke ly candida te beca use som e studies h ave 
used PC R primers capable of detecti ng H TL V -II and have no[ 
found evidence of it ill CTCL, except for ra re cases (Lisby el ai, 
1992; Z ucker-Franklin er nl , 1992; G hosh et nl, 1994 ; Pancake c/ al. 
1995; Li e ( ,,1,1996). 
[n conclusion , our find ings indicate that PC R-based studies of 
CTCL that show positive results for H TLV-! o r allY other virus 
sho uld be viewed skeptically, especially if they do not involve 
controls fo r each of the artifacts discllssed earlie r o r are not 
reproducible in repeat experim ents and in new s<l l1lples fi'oJ11 the 
same cases. It W<lS not lo n g ago that PCR da ta con tributed to 
controversy con cerning whethe r H TLV-l was in volved in the 
pathogenesis of multiple scle rosis. Eventually, however, the pre-
ponderan ce of evidence indicated that it was not (Antel and 
Cashman. 199 1; Prayoonwiwat et nl, 199 1) . Altho ugh the recent 
controversy con cerning its ro le in CTCl is not likely to end SOOl1. 
HTLV -I remains innoccnt until proved guilty. 
SlIpported by NOfitmol IlIsfiflllt 'S of H eoltlt (NIH) CrOft!s CA 60014, AR408.J.J, 
Of/(I A R39750; Merif Rell iell' jimriillgji'<llll Iii " Dl'porllll ""f '!f f/c!crn lls A.Dn;r.< (Dr. 
Wood); o"d N IH C row A fW I 850 (Dr. [(illl). 
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